Clinical pharmacology
- stabilises neuronal membranes and reduces the release of excitatory amino acids, especially glutamate, by blocking voltage-sensitive sodium channels
- rapid and complete absorption after oral administration
- metabolised in the liver, largely by glucorinidation, and has an elmination half-life of 25-30 hours
- about 55% protein-binding
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.